Nektar Therapeutics

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC NKTR

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

208,662

Value ($000)

147

Weight

0.0%

2013 Q4 - 2023 Q2 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	147	0.0%	208,662	6/30/2023
2023 Q1	5/15/2023	147	0.0%	208,662	3/31/2023
2022 Q4	2/14/2023	378	0.0%	167,179	12/31/2022
2022 Q3	11/14/2022	535	0.0%	167,179	9/30/2022
2022 Q2	8/12/2022	741	0.0%	194,902	6/30/2022
2022 Q1	5/16/2022	1,638	0.0%	303,974	3/31/2022
2021 Q4	2/14/2022	3,534	0.0%	261,557	12/31/2021
2021 Q3	11/15/2021	4,666	0.0%	259,815	9/30/2021
2021 Q2	8/16/2021	4,458	0.0%	259,815	6/30/2021
2021 Q1	5/14/2021	5,052	0.0%	252,586	3/31/2021
2020 Q4	3/1/2021	4,320	0.0%	254,093	12/31/2020
2020 Q3	11/13/2020	3,631	0.0%	218,864	9/30/2020
2020 Q2	8/14/2020	4,960	0.0%	214,157	6/30/2020
2020 Q1	5/15/2020	4,399	0.0%	246,424	3/31/2020
2019 Q4	2/14/2020	4,924	0.0%	228,131	12/31/2019
2014 Q1	5/23/2014	3,114	0.0%	256,920	3/31/2014
2013 Q4	1/31/2014	3,148	0.0%	277,362	12/31/2013